Study of minimal residual disease in B-Cell lineage acute lymphoblastic leukemia of childhood, using clone-specific probes

Anticancer Research

Volumn 19, Issue 3 B, 1999, Pages 2211-2220

  Botsonis, Thanassis ^a   Tsangaris, George T H ^a   Mikraki, Vassiliki ^a   Tzortzatou Stathopoulou, Fotini ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Immunoglobulin gene rearrangements; Polymerase chain reaction; Sequencing

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; B LYMPHOCYTE; BONE MARROW BIOPSY; CELL LINEAGE; CHILD; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; CYTOGENETICS; FEMALE; FOLLOW UP; GENE LOCUS; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LEUKEMIA CELL; MALE; MICROSCOPY; MINIMAL RESIDUAL DISEASE; OLIGONUCLEOTIDE PROBE; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; RELAPSE; REMISSION; SEQUENCE ANALYSIS;

BASE SEQUENCE; BONE MARROW; CHILD; CHILD, PRESCHOOL; FEMALE; GENE REARRANGEMENT; GENES, IMMUNOGLOBULIN; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOPHENOTYPING; LEUKEMIA, B-CELL, ACUTE; MALE; MOLECULAR SEQUENCE DATA; NEOPLASM, RESIDUAL; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

EID: 0032796097     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Maloum K, Pritsch O, Dighiero G: Minimal residual disease detection in B-cell malignancies by assessing IgH rearrangement. Hematol Cell Ther 39: 119-124, 1997.
2. Rolink A, Melchers F: Generation and regeneration of cells of the B-lymphocyte lineage.Curr Opin Immunol 5: 207-217, 1993.
3. Ehlich A, Schaal S, Gu H, Kitamura D, Muller W, Rajewsky K: Immunoglobulin heavy and light chain genes rearrange independently at early stages of B-cell development. Cell 72: 695-704, 1993.
4. Alt FW, Blackwell TK, DePinho RA, Reth MG, Yancopoulos GD: Regulation of genome rearrangement events during lymphocyte differentiation. Immunol Rev 89: 5-29, 1986.
5. Tonegawa S: Somatic generation of antibody diversity. Nature 302: 575-581, 1983.
6. Cook GP, Tomlinson I: The human immunoglobulin VH repertoire. Immunol Today 16: 237-242, 1995.
7. Arnold A, Cossman J, Bakhshi A, Jaffe ES, Waldmann TA, Korsmeyer SJ: Immunoglobulin-gene rearrangements as unique clonal markers in human lymphoid neoplasms. N Engl J Med 309: 1593-1599, 1983.
8. Baruchel A, Cayuela JM, MacIntyre E, Berger R, Sigaux F: Assessment of clonal evolution at Ig/TCR loci in acute lymphoblastic leukaemia by single-strand conformation polymorphism studies and highly resolutive PCR derived methods: implication for a general strategy of minimal residual disease detection. Br J Haematol 90: 85-93, 1995.
9. Beishuizen A, Verhoeven MA, van Wering ER, Hahlen K, Hooijkaas, van Dongen JJ: Analysis of Ig and T-cell receptor genes in 40 childhood acute lymphoblastic leukemias at diagnosis and subsequent relapse: implications for the detection of minimal residual disease by polymerase chain reaction analysis. Blood 83: 2238-2247, 1995.
10. Potter MN, Cross NC, van Dongen JJ, Saglio G, Oakhill A, Bartram CR, Goldman JM: Molecular evidence of minimal residual disease for leukaemia and lymphoma: an updated meeting report and review. Leukemia 7: 1302-1314, 1993.
11. Ito Y, Wasserman R, Galili N, Reichard BA, Shane S, Lange B, Rovera G: Molecular residual disease status at the end of chemotherapy fails to predict subsequent relapse in children with B-lineage acute lymphoblastic leukemia. J Clin Oncol 11: 546-553, 1993.
12. Ito Y, Miyamura K: Clinical significance of minimal residual disease in leukemia detected by polymerase chain reaction: is molecular remission a milestone for achieving a cure?. Leuk Lymphoma 16: 57-64, 1994.
13. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, New York, 1989.
14. Greenberg SJ, Choi Y, Ballow M, Du TL, Ward PM, Rickert MH, Frankel S, Bernstein SH, Brecker ML: Profile of immunoglobulin heavy chain variable gene repertoires and highly selective detection of malignant clonotypes in acute lymphoblastic leukemia. J Leukoc Biol 57: 856-864, 1995.
15. Deane M, Norton JD: Immunoglobulin gene 'fingerprinting': an approach to analysis of B lymphoid clonality in lymphoproliferative disorders. Br J Haematol 77: 274-281, 1991.
16. Yamada M, Hudson S, Tournay 0, Bittenbender S, Shane SS, Lange B, Tsujimoto Y, Caton AJ, Rovera G: Detection of minimal disease in hemopoietic malignancies of the B-cell lineage by using third-complementarily-determining region (CDR-III) specific probes. Proc Natl Acad Sci USA 86: 5123-5127, 1989.
17. Yamada M, Wasserman R, Lange B, Reichard BA, Womer RB, Rovera G: Minimal residual disease in childhood B-lineage lymphoblastic leukemia. N Engl J Med 323: 448-455, 1990.
18. Pui C-H, Christ WM, Look AT : Biology and clinical significance of cytogenetic abnormalities in childhood acute lymphoblastic leukemia. Blood 76: 1449-1463, 1990.
19. Cleary ML, Galili N, Trela M, Levy R, Sklar J: Single cell origin of bigenotypic and biphenotypic B-cell proliferations in human follicular lymphomas. J Exp Med 167: 582-597, 1988.
20. Potter MN, Steward CG, Oakhill A: Clonal instability in early B-lineage acute lymphoblastic leukemia. Blood 80: 1630-1631, 1992.
21. Bird J, Galili N, Link M, Stites D, Sklar J: Continuing rearrangement but absence of somatic hypermutation in immunoglobulin genes of human B cell precursor leukemia. J Exp Med 168: 229-245, 1988.
22. Carter M, Neale GAM, Kitchingman GR: Characterization of immunoglobulin heavy chain genes from an acute lymphoblastic leukemia with four rearrangements. Leukemia 5: 668-672, 1991.
23. Davi F, Gocke C, Smith S, Sklar J: Lympocytic progenitor cell origin and clonal evolution of human B-lineage acute lymphoblastic leukemia. Blood 88: 609-621, 1996.
24. Reth M, Gehmann P, Petrac E, P. W: A novel VH to VHDJH joining mechanism in heavy-chain-negative (null) pre-B cells results in heavy-chain production. Nature 322: 840-842, 1986.
25. Reth MG, Jacson S, Alt FW: VHDJH formation and DJH replacement during B-cell differentiation: Non-random usage of gene segments. EMBO J 5: 2131-2138, 1986.
26. Hayashi Y, Pui c-h, Behm FG, Fuchs AH, Raimondi SC, Kitchingman GR, Mirro J Jr, Williams DC: 14q32 tranlsocations are associated with mixed-lineage expression in childhood acute leukaemia. Blood 76: 150-156, 1990.
27. Dyer MJS, Heward JM, Zani VJ, Buccheri V, Catovsky D: Unusual deletions within the IgH heavy-chain locus in acute leukemias. Blood 82: 865-871, 1993.
28. Seriu T, Yokota S, Nakao M, Misawa S, Takaue Y, Koizumi S, Kawai S, Fujimoto T: Prospective monitoring of minimal residual disease during the course of chemotherapy in patients with acute lymphoblastic leukemia, and detection of contaminating tumor cells in peripheral blood stem cells for autotransplantation. Leukemia 9: 615-623, 1995.
29. Cave H, van der Werff ten Bosch J, Suciu S, Guidal C, Waterkeyn C, Otten J, Bakkus M, Thielemans K, Grandchamp B, Vilmer E: Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer Childhood Leukemia Cooperative Group. N Engl J Med 9: 591-598, 1998.
30. Gruhn B, Hongeng S, Yi H, Hancock ML, Rubnitz JE, Neale GA, Kitchingman GR: Minimal residual disease after intensive induction therapy in childhood acute lymphoblastic leukemia predicts outcome. Leukemia 5: 675-681, 1998.
31. Foroni L, Coyle LA, Papaioannou M, Yaxley JC, Sinclair MF, Chim JS, Canell P, Seeker-Walker LM, Mehta AB, Prentice HG, Hoffbrand AV: Molecular detection of minimal residual disease in adult and childhood acute lymphoblastic leukaemia reveals differences in treatment response. Leukemia 11: 1732-1741, 1997.
32. Potter MN, Steward CG, Oakhill A: The significance of minimal residual disease in childhood acute lymphoblastic leukaemia. Br J Haematol 83: 412-418, 1993.
33. Roberts WM, Estrov Z, Ouspenskaia MV, Johnston DA, McClain KC, Zipf T: Measurement of residual leukemia during remission in childhood acute lymphoblastic leukemia. N Engl J Med 336: 317-323, 1997.
34. Cole-Sinclair MF, Foroni L, Hoffbrand AV: Genetic changes: relevance for diagnosis and detection of minimal residual disease in acute lymphoblastic leukaemia. Baillieres Clin Haematol 7: 183-233, 1994.